GXO saw revenue leap 21% to $3bn (£2.27bn) in the first quarter of 2025 and landed $228m (£173m) of new business, including its recently announced £2.5bn deal with the National Health Service Supply Chain, the company has revealed.
Please login or create a FREE account to read the full article
Once registered, you’ll get access to: